Company / Goodwill
Haemonetics Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$604.3M
FY2025
5-year range
$466.2M / $604.3M
FY2021-FY2025
Trend
+6.9%
vs FY2024
Sector context
#83 of 141
Health Care
What the data says
At $604M, Haemonetics's goodwill ranks #83 of 141 in the Health Care sector. Goodwill has fluctuated over the past 10 years, ranging from $211M in FY2020 to $604M in FY2025.
Based on SEC 10-K filings.
$604M in FY2025 with a 5-year CAGR of +23.5%.
Improved from $466M to $604M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- +23.5%
- 10-Year CAGR
- -
Sector benchmark
#83 of 141 in Health CareTop 59% of 141This company $604.3M Sector average $5.4B
▼
-88.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.5%, indicating consistent growth.
- In FY2025, goodwill increased 6.9% year-over-year.
- Ranks #83 out of 141 companies in the Health Care sector.
- Lowest goodwill in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $604.3M | +6.9% |
| FY2024 | $565.1M | +21.2% |
| FY2023 | $466.2M | -0.2% |
| FY2022 | $467.3M | +0.2% |
| FY2021 | $466.4M | +121.4% |
| FY2020 | $210.7M | -0.1% |
| FY2019 | $210.8M | -0.3% |
| FY2018 | $211.4M | +0.3% |
| FY2017 | $210.8M | -21.3% |
| FY2016 | $267.8M | -19.9% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026